Kedaling

**Kedaling** is an oral Chinese patent medicine supplied as tablets and derived from *Corydalis yanhusuo*. It is marketed in China by Zhejiang Conba Pharmaceutical for coronary heart disease-related use. Dehydrocorydaline hydrochloride is the product's stated quality-control constituent, with each tablet containing 2.4 mg; however, Kedaling is a multicomponent botanical preparation rather than a pure dehydrocorydaline drug. Published analytical work identified numerous constituents, including canadine, tetrahydropalmatine, dehydrocorydaline, and stylopine. Its molecular pharmacology has not been conclusively established. ([trial.medpath.com](https://trial.medpath.com/drug/approvals/nmpa/7LeaflZJR6k))

Brand names

Conba Kedaling

Other names

可达灵片Kedaling Tablets